Status of TTT in the therapy for CNV;Stand der TTT bei der therapie der CNV

Klinische Monatsblatter fur Augenheilkunde

Volumn 223, Issue 10, 2006, Pages 802-807

  Feucht, M ^a   Fuisting, B ^a   Richard, G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Choroidal neovascularisation; Heat shock proteins; Low grade hyperthermia; Transpupillary thermotherapy

Indexed keywords

HEAT SHOCK PROTEIN; PHOTOSENSITIZING AGENT;

CHOROID TUMOR; CONTROLLED STUDY; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; LASER COAGULATION; OUTCOME ASSESSMENT; PHOTOCHEMISTRY; PHOTOTHERAPY; REVIEW; SUBRETINAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; VISUAL IMPAIRMENT;

CHOROIDAL NEOVASCULARIZATION; GERMANY; HUMANS; HYPERTHERMIA, INDUCED; PHOTOCHEMOTHERAPY; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PUPIL; TREATMENT OUTCOME;

EID: 33845259328     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-926741     Document Type: Review

References (63)

1. Algvere PV, Libert C, Lindgärde G et al. Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up. Acta Ophthalmol Scand 2003; 81: 110-117
2. Atarashi T, Tamaki Y, Inoue Y et al. Transpupillary thermotherapy for treatment of exsudative age-related macular degeneration in Japanese patients. Eye 2004; 18: 615-618
3. Auer C. Tao neovessels in age-related macular degeneration: importance of patient pigmentation for the determination of laser settings. Klin Monatsbl Augenheilkd 2002; 219: 250-253
4. Bressler SB, Bressler NM, Fine SL et al. Natural course of choroidal neovascular membranes within the foveal avascular zone in senile macular degeneration. Am J Ophthalmol 1982; 93: 157-162
5. Bressler NM, Frost LA, Bressler SB et al. Natural course of poorly defined neovascularization associated with pmacular degeneration. Arch Ophthalmol 1988; 106: 1537-1542
6. Bressler NM, Bressler SB. Preventive Ophthalmology: Age-related macular degeneration. Ophthalmology 1995; 102: 1206-1211
7. Bressler NM, Rosenfeld PJ, Lim JI et al. A phase 11 placebo controlled, double-masked, randomized trial - Verteporfin in minimally classic CNV due to AMD (VIM). Invest Ophthalmol Vis Sci 2003; 44: 1100
8. Cain CP, Welch AJ. Measured and predicted laser-induced temperature rises in the rabbit fundus. Invest Ophthalmol 1974; 13: 60-70
9. Feucht M, Fuisting B, Richard G. Transpupillare Thermotherapie für subfoveale choroidale Neovsakularisation bei Alters-korrelierter Makuladegeneration. Der Ophthalmologe 2004; 101: 1105-1110
10. Fingar VH, Wilman TJ, Wiehle SA. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability and leukocyte adhesion. Cancer Res 1992; 52: 4914-4921
11. Flower RW, Snyder WJ. Expanded hypothesis on the mechanism of photodynamic therapy action on choroidal neovascularization. Retina 1999; 19: 365-369
12. Gregor Z, Bird AC, Chisholm IH. Senile disciform macular degeneration in the second eye. Br J Ophthalmol 1977; 61: 141-147
13. Haas A, Feigl B, Weger M. Transpupillare Thermotherapie bei exsudativer altersabhängiger Makuladegeneration. Der Ophthalmologe 2003; 100: 111-114
14. Ham Jr WT, Mueller HA, Sliney DH. Retinal sensitivity to damage from short wavelength light. Nature 1976; 260: 153-155
15. Ibarra MS, Hsu J, Mirza N et al. Retinal temperature increase during transpupillary thermotherapy: effects of pigmentation, subretinal blood, and choroidal blood flow. Invest Ophthalmol Vis Sci 2004; 45: 3678-3682
16. Jaattela M. Heat shock proteins as cellular lifeguards. Ann Med 1999; 31: 261-271
17. Juhnius P, Kuhnt H. Die scheibenförmige Entartung der Netzhautmitte. Berlin: Karger, 1926: 132
18. Karel I, Zahlava J, Boguszakova J et al. Transpupillary thermotherapy in age-related macular degeneration. Cesk Slov Oftalmol 2005; 61: 154-165
19. Kim JF, Perkins SL, Schwiesow T et al. Transpupillary thermotherapy of occult choroidal neovascularization in age-related macular degeneration. Semin Ophthalmol 2001; 16: 86-89
20. Klein ML. Age-related macular degeneration. In: Fraunfelder FT, Roy FH (Hrsg). Current ocular therapy 3. Philadelphia/London/Toronto: WB Saunders, 1990: 623-624
21. Klein R, Klein BEK, Wang Q et al. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology 1992; 99: 933-943
22. Krott R, Heimann K. Altersabhängige Makuladegeneration. Dt Ärztebl 1996; 93: 1039-1042
23. Leibowitz H, Krueger DE, Maunder LR et al. The Framingham Eye Study Monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1977. Surv Ophthalmol 1980; 24: 335-610
24. Lin SF, Lin PK, Lin JH. The long-term resluts of one time treatment by continuously fractionated transpupillary thermotherapy for occult choroidal neovascularization membrane of age-related macular degeneration. J Chin Med Assoc 2003; 66: 528-532
25. Macular Photocoagulation Study Group. Recurrent choroidal neovascularization after argon laser photocoagulation for neovascular maculopathy. Arch Ophthalmol 1986; 104: 503-512
26. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions in age-related macular degeneration: Results of a randomised clinical trial. Arch Ophthalmol 1990; 108: 816-824
27. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration: Results of a randomised clinical trial. Arch Ophthalmol 1994; 109: 1220-1231
28. Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoeal choroidal neovascularization. Five-years results from randomised clinical trials. Arch Ophthalmol 1994; 112: 500-509
29. Macular Photocoagulation Study Group. Occult choroidal neovascularization: Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996: 114: 400-412
30. Mainster MA, White TJ, Tips JH et al. Retinal-temperature increases produced by intense light sources. J Opt Soc Am 1974; 60: 264-270
31. Mainster MA. Retinol transport and the regeneration of human cone photopigment. Nat New Biol 1972; 238: 223-224
32. Mainster MA, Ham Jr WT, Delori FC. Potential retinal hazards. Instrument and environmental light sources. Ophthalmology 1983; 90: 927-932
33. Mainster MA. Wavelength selection in macular photocoagulation. Tissue optics, thermal effects, and laser systems. Ophthalmology 1986; 93: 952-958
34. Mainster MA. Laser therapy for neovascular macular degeneration: analysis of mechanisms. Lasers Light Ophthalmol 1987; 1: 167-176
35. Mainster MA, Reichel E. Transpupillary thermotherapy for Age-Related Macular Degeneration: Long-Pulse Photocoagulation, Apoptosis, And Heat Shock Proteins. Ophthalmic Surg Lasers 2000; 31: 359-373
36. Marshall J. Thermal and mechanical mechanisms in laser damage to the retina. Invest Ophthalmol 1970; 9: 97-115
37. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthalmol Vis Sci 1986; 27: 1644-1652
38. Miller H, Miller B, Ishibashi T et al. Pathogenesis of laser-induced choroidal subretinal neovascularization. Invest Ophthalmol Vis Sci 1990; 31: 899-908
39. Miller-Rivero NE, Kaplan HJ. Transpupillary Thermotherapy in the Treatment of Occult and Classic Choroidal Neovascularizations. Invest Ophthalmol Vis Sci 2000; 41 (4): 179
40. Newsam RSB, McAlister JC, Saeed M et al. Transpupillary thermotherapy (TTT) for the treatment of choroidal neovascularization. Br J Ophthalmol 2001; 85: 173-178
41. Ogata N, Jo N, Wong L et al. Upregulationn of pigment epithelium-derived factor (PEDF) following laser photocoagulation. Invest Ophthalmol Vis Sci 2000; 41 (4): 656
42. Pauleikhoff D, Harper CA, Mashall J et al. Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology 1990; 97: 171-178
43. Pauleikhoff D, Spital G. Photodynamische Therapie bei Alters-korrelierter Makuladegeneration: Strategien zur Indikation. Der Ophthalmologe 2004; 101: 1224-1230
44. Peyman GA, Genaidy M, Yoneya S et al. Transpipillary thermotherapy threshold parameters: effect of indocyanine green pretreatment. Retina 2003; 23: 378-386
45. Polhamus GD, Welch AJ. Threshold lesion temperatures in argon laser-irradiated rabbit eyes. J Heat Transfer (Trans Am Soc Mechanical Eng) 1975; 97: 457-462
46. Priebe LA, Cain CP, Welch AJ. Temperature rise required for production of minimal lesions in the Macaca mulatta retina. Am J Ophthalmol 1975; 79: 405-413
47. Reichel E, Berrocal AM, Ip M. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999; 106: 1908-1914
48. Richard G, Böhm A. Aktueller Stand der Makulachirurgie. Der Ophthalmologe 1999; 96: 622-634
49. Rosenfeld PJ VIM Study Group. Verteporfin in minimally classic CNV due to AMD (VIM). Two-year results from a phase II controlled clinical trial. Invest Ophthalmol Vis Sci 2004; 45: 2273
50. Schmidt-Erfurth U, Hasan T, Gragoudas E. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 1994; 101: 1953-1961
51. Schule G, Huttmann G, Framme C et al. Noninvasive optoacoustic temperature determination at the fundus of the eye during lase irradiation. J Biomed Opt 2004; 9: 173-179
52. Sharma T, Shah N, Gopal L et al. Indocyanine green enhanced transpupillary thermotherapy of classic subfoveal choroidal neovascularization. Ophthalmic Surg Lasers Imaging 2004; 35: 197-200
53. Sliney DH, Wolbarsht ML. Safety with Lasers and Other Optical Sources: A Comprehensive Handbook. New York: Plenum Press, 1980
54. Spindler V. Aktueller Stand der Behandlung der Makula. Ophthalmologe 1998; 95: 64-67
55. Stevens TS, Bressler NM, Maguire MG et al. Occult choroidal neovascularization in age-related macular degeneration: a natural history study. Arch Ophthalmol 1997; 115: 345-350
56. Thach AB, Sipperley JO, Dugel PU et al. Large-spot size transpupillary thermotherapy for the treatment of occult choroidal neovascularization associated with age-related macular degeneration. Arch Ophthalmol 2003; 121: 817-820
57. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials - TAP report 1. Arch Ophthalmol 1999; 117: 1329-1345
58. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2. Arch Ophthalmol 2001; 119: 198-207
59. Verteporfin In Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: one-year results of a randomized clinical trial - VIP report 1. Ophthalmology 2001; 108: 841-852
60. Verteporfin In Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: two-year results of a randomized clinical trial - VIP report 2. Am J Ophthalmol 2001; 131: 541-560
61. Xiao M, Sastry SM, Li ZY. Effects of retinal laser photocoagulation on photoreceptor basic fibroblast growth factor and survival. Invest Ophthalmol Vis Sci 1998; 39: 618-630
62. Xiao M, McLeod D, Cranley J et al. Growth factor staining patterns in the pig retina following retinal laser photocoagulation. Br J Ophthalmol 1999; 83: 728-736
63. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987; 31: 291-306